ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,342Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 68

$577K Total Retail Price of All Prescriptions

Rank: 15 out of 68

426 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

11% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 821 814 1 5
LEVOTHYROXINE SODIUM 731 727 2 2
JANTOVEN 572 571 3 24
AMLODIPINE BESYLATE 541 541 4 7
LISINOPRIL 536 536 5 4
SIMVASTATIN 486 482 6 1
METOPROLOL TARTRATE 431 431 7 6
FUROSEMIDE 428 428 8 3
CITALOPRAM HBR 423 419 9 9
HYDROCHLOROTHIAZIDE 326 323 10 11
METOPROLOL SUCCINATE 274 274 11 19
ALENDRONATE SODIUM 262 252 12 26
DONEPEZIL HCL 245 245 13 10
MIRTAZAPINE 233 230 14 15
SERTRALINE HCL 222 222 15 20
ATENOLOL 211 211 16 21
POLYETHYLENE GLYCOL 3350 211 209 16 22
GLIMEPIRIDE 201 201 18 69
CARBIDOPA-LEVODOPA 188 188 19 50
ZOLPIDEM TARTRATE 176 176 20 53
ATORVASTATIN CALCIUM 175 174 21 13
GABAPENTIN 172 172 22 12
POTASSIUM CHLORIDE 165 162 23 18
QUETIAPINE FUMARATE 150 150 24 33
HYDROCODONE-ACETAMINOPHEN 149 149 S3 25 17
CARVEDILOL 145 145 26 27
NAMENDA 143 143 27 16
FAMOTIDINE 140 140 28 56
METFORMIN HCL 137 137 29 14
LOSARTAN POTASSIUM 136 136 30 37
ENALAPRIL MALEATE 136 136 30 61
BUMETANIDE 127 121 32 58
KLOR-CON 10 120 120 33 142
LANTUS 117 117 34 36
TAMSULOSIN HCL 117 116 34 28
TRIAMCINOLONE ACETONIDE 107 106 36 85
ALLOPURINOL 89 89 37 46
CRESTOR 85 85 38 90
CLOPIDOGREL 82 82 39 31
NOVOLOG 80 80 40 78
MORPHINE SULFATE 75 74 S2 41 135
ESCITALOPRAM OXALATE 72 72 42 38
PLAVIX 69 69 43 48
TRAMADOL HCL 68 65 44 23
TRAZODONE HCL 67 67 45 32
BISOPROLOL FUMARATE 67 67 45 256
FLUTICASONE PROPIONATE 67 67 45 66
DIGOXIN 67 67 45 45
NYSTATIN 66 64 49 74
ISOSORBIDE MONONITRATE ER 66 66 49 35
GLIPIZIDE 64 64 51 54
LATANOPROST 63 63 52 63
DIOVAN 63 63 52 42
KLOR-CON M20 61 61 54 40
OXYBUTYNIN CHLORIDE ER 61 61 54 81
PROPRANOLOL HCL 59 59 56 172
FINASTERIDE 57 56 57 70
SYNTHROID 57 57 57 102
NEXIUM 57 57 57 62
PAROXETINE HCL 56 53 60 93
OXYCODONE HCL 54 54 S2 61 75
SEROQUEL 54 54 61 71
LIDODERM 54 54 61 68
AMOXICILLIN 53 53 64 116
BUSPIRONE HCL 53 53 64 98
VENLAFAXINE HCL ER 52 52 66 84
LEVOXYL 51 51 67 135
MORPHINE SULFATE ER 50 50 S2 68 114
FENOFIBRATE 50 50 68 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.